Skip to main content

Table 2 Patient-Centered Outcomes

From: A Sequential Multiple Assignment Randomized Trial (SMART) study of medication and CBT sequencing in the treatment of pediatric anxiety disorders

DOMAIN

Instrument

Reporter

Ages

# Items

Reliability

Minutes

Timing

(week number)

Telehealth Acceptability

Telehealth Acceptability Questionnaire

C,P,Cl

8–17

15

N/A

3

1,12

Telehealth Acceptability

Process Evaluation for Acceptability

C,P,Cl

8–17

4

N/A

10

12

Anxiety Symptoms

SCARED [86]

C,P

7–17

41

.90

9

B,6,12,18,24,Q

Functional Impairment

Child Anxiety Impact Scale [87,88,89]

C,P

7–17

28

.70–.90

5

B,12,24,Q

Patient-Identified Treatment Needs

Youth Top Problems [90]

C

All

6

69–.88

3

B,12,24,Q

Well-Being

PROMIS Purpose & Meaning Short Form [91]

C,P

All

8

.90–.98

1

B,12,24,Q

Life Satisfaction

NIH Toolbox Life Satisfaction [92]

C,P

3–17

5

.86–.97

3

B,12,24,Q

Self-Efficacy

NIH Toolbox Self-Efficacy [93]

C,P

7–17

10

.90–.92

3

B,12,24,Q

Family Functioning

Family Assessment Device [94]

C,P

12+

12

.69–.84

5

B,12,24,Q

Social Functioning

NIH Toolbox Social Relations & Loneliness [92]

C

7–17

29

.95

10

B,12,24,Q

School Functioning

Grade point average

Report card

N/A

N/A

N/A

N/A

B,12,24,Q

School attendance

Report card

N/A

N/A

N/A

N/A

B,12,24,Q

Student Subjective Wellbeing Questionnaire

C

7–17

16

.92

4

B,12,24,Q

Sleep

Sleep Self Report [95]

C

7–12

26

.76

7

B,12,24,Q

Children’s Sleep Habits Questionnaire [96]

P

4–10

23

.68–.78

7

B,12,24,Q

Emotion Regulation

Brief Version of the Difficulties in Emotion Regulation Scale (DERS-16) [97, 98]

C

11–17

16

.92

2

B,12,24,Q

Coping with Change

Anxiety Control Questionnaire for Children [99, 100]

C

8–18

10

.89

2

B,12,24,Q

Comorbid Psychiatric Symptoms

Child Behavior Checklist [101]

Youth Self-Report [102]

C,P

6–17

11–17

83

112

.78–.97

.71–.95

12

B,12,24,Q

Mood and Feelings Questionnaire [103]

C,P

All

13

 

5

B,12,24,Q

Side Effects

The Pediatric Side-Effect Checklist

C,P,Cl

All

24

.78

5

B,6,12,18,24,Q

Suicidal Ideation

Columbia-Suicide Severity Rating Scale [104]

C

All

6

.73–.93

2

B,12,24,Q

Family’s Accommodation of Patient’s Symptoms

Family Accommodation Scale-Anxiety [105]

P

All

13

.82–.90

3

B,12,24,Q

Treatment Expectations

Treatment Expectancies [106]

C,P,Cl

All

3

N/A

2

B,M

Service Use

Anxiety Disorders Interview Schedule For DSM-5 (ADIS), the supplemental service form (SSF) [107]

P

All

5

N/A

5

B,12,24,Q

Treatment Preferences

Treatment Acceptability and Preferences [108]

C,P

All

2

.88

5

B,12

Clinician Relatedness & Therapeutic Alliance

Outcome Rating Scale and Session Rating Scale [109]

C,P,Cl

All

8

.87–.96 & .88

1

B,M

Anxious Avoidance

Child Avoidance Measure [110]

C,P

8–18

8

.86–.91

3

B,M,Q

Parent Anxiety & Depression Symptoms

PHQ9 & GAD7 [111, 112]

P

All

16

0.83–0.92 ([111, 112])

3

B,12,24

  1. C=Child-report; P=Parent-report; Cl = Clinician-report
  2. B=Baseline; 6 = Week 6; 12 = Week 12; 18 = Week 18; 24 = Week 24; Q = Quarterly Follow-up; M = Monthly, every 4 weeks during the 24-week trial
  3. Child Total Time: 93 min
  4. Parent Total Time: 78 min
  5. Clinician Total time: 10 min